We are proud to announce a partnership w/Provation! 1st up: an #AI-based patient recruiting solution for #IBD clinical trials to reduce the time needed to bring new therapies to market and increase access to appropriate patient care 🎉globenewswire.com/news-release/2…

Bringing AI to endoscopy in IBD is going to truly disruptive. Jonathan Ng and team @IterativeScopes have a big bold vision. I’m pleased to work with them and am looking forward to helping deliver the fruits of this collaboration.

3 years into my vision of changing up the practice of GI, we hit this one out of the park :)

What a wonderful message to send out to the world.

So many exciting developments over the last year, but our mission at @IterativeScopes to infuse computational gastroenterology into the clinic is just beginning. So excited to bring on Obvious Ventures, Former Account of Eli Lilly and Company,Johnson & Johnson Innovation, Seae Ventures and Jim Breyer. Come join us! 🚀🚀🚀

Announcing our Series A, led by Obvious Ventures, joined by Former Account of Eli Lilly and Company, Johnson & Johnson Innovation, Seae Ventures and Breyer Cap (Jim Breyer). Thrilled to have leaders in healthcare who have defined their categories over the last decade: Lee Shapiro, Tweets from Zach Weinberg, Nat Turner, Chris Gibson

Excited to partner with Jonathan Ng and team at @IterativeScopes! Epic opportunity to advance the standard of care in GI disease. Let’s get to work 💪